Data / Form D filings / DX Biosciences, Inc.
DX Biosciences, Inc.: Form D filings
DX Biosciences, Inc., a company in San Diego, CA, filed 2 Form D notices with the SEC between 2010 and 2013. The latest, on March 7, 2013, reports $529,386 sold of a $1.6 million offering to 6 investors.
Find out what DX Biosciences, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10620 TREENA STREET, SUITE 230, San Diego, CA, 92131
- Phone
- (713) 622-4880
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2010
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1504072
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in other industries: 9,873 rows, $178.73, or the new rows each week for $19.10 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 7, 2013 | New notice | $1,588,154 | $529,386 | $1,058,768 | 6 | Feb 25, 2013 | sec.gov |
| Nov 16, 2010 | New notice | $900,000 | $300,000 | $600,000 | 5 | Oct 25, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Daniel Haimovic | Director | |
| Samir Mitragotri | Director | |
| Russell Lebovitz | Executive Officer, Director | |
| Robert Langer | Director | |
| Frank Foster | Director | |
| Sallie Cassel | Executive Officer |
Other companies in California that filed recently
- D'LUX Storage, Inc. $249,993 · Nov 9, 2026
- Ubicloud Inc. $49.6 million · Nov 9, 2026
- Zevia PBC $15 million · Nov 6, 2026
- Series 24-1, a series of StartEngine Private Funds LLC $518,980 · Nov 5, 2026
- PrimePrix Capital Inc $9 million · Nov 5, 2026
- NOVA BOULDERS LLC $621,504 · Nov 5, 2026
- Rasa World Group, Inc. $9.3 million · Nov 5, 2026
- Pelorus Growth Fund, LLC $3.6 million · Nov 5, 2026
- Roq.ad Inc. $10.9 million · Nov 4, 2026
- Series 95-1, a series of StartEngine Private LLC $129,900 · Nov 4, 2026
- CH Common Ground Group LLC $350,000 · Nov 3, 2026
- MoFlo Acquisitions, Inc. $587.5 million · Nov 2, 2026
- BC Movie, LLC offering · Nov 2, 2026
- Jana Education San Jose LLC $200,000 · Nov 2, 2026
- Crosscut SPV Frontier LP - Series 2 $23.4 million · Oct 30, 2026
Every Form D from the week of Mar 4, 2013 · All recent filings in California · All recent Other filings
Read from SEC EDGAR. Amount sold is what DX Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.